| |
| |
|
| Insider
Information: |
Rosenberger Brian |
| Relationship: |
|
| City: |
Devon |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 40.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zynerba Pharmaceuticals, Inc. |
ZYNE |
|
2023-10-10 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• • – |
2023-10-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(369,559) |
0 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• • – |
2023-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
300,000 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2023-09-13 |
4 |
S |
$1.33 |
$8,499 |
D/D |
(6,411) |
249,559 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2023-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
22,200 |
255,970 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2023-02-08 |
4 |
D |
$0.60 |
$3,069 |
D/D |
(5,145) |
233,770 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2023-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
14,926 |
238,915 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2023-02-01 |
4 |
D |
$0.60 |
$2,862 |
D/D |
(4,809) |
223,989 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,950 |
228,798 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2023-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
214,848 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2023-01-23 |
4 |
S |
$0.60 |
$7,570 |
D/D |
(12,663) |
94,848 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2022-07-19 |
4 |
S |
$1.10 |
$4,718 |
D/D |
(4,289) |
107,511 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2022-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
14,800 |
111,800 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
97,000 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
VP, Commercial & Business Dev. |
• – – |
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
37,000 |
37,000 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
